AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
10.80
+0.20 (1.89%)
Mar 16, 2026, 1:40 PM EDT - Market open

AngioDynamics Income Statement

Millions USD. Fiscal year is Jun - May.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 May '25 May '24 May '23 May '22 May '21
307.31292.5303.91338.75316.22291.01
Revenue Growth (YoY)
7.26%-3.76%-10.28%7.13%8.66%10.17%
Cost of Revenue
139.59134.79149.22164.51150.49134.22
Gross Profit
167.72157.71154.7174.25165.73156.79
Selling, General & Admin
150.21145.23143.98144.25133.75117.22
Depreciation & Amortization Expenses
10.4810.3213.0518.7919.4618.14
Research & Development
27.6926.2231.5129.8830.7436.39
Other Operating Expenses
11.8715.89158.5932.510.2520.32
Total Operating Expenses
200.26197.66347.13225.43194.2192.07
Operating Income
-32.54-39.95-192.44-51.18-28.47-35.28
Other Non-Operating Income (Expense)
4.515.920.8-3.26-1.48-0.77
Total Non-Operating Income (Expense)
4.835.920.8-3.26-1.48-0.77
Pretax Income
-27.71-34.03-191.64-54.44-29.95-36.05
Provision for Income Taxes
-0-0.04-7.29-2-3.4-4.5
Net Income
-27.71-33.99-184.35-52.44-26.55-31.55
Net Income to Common
-27.71-33.99-184.35-52.44-26.55-31.55
Shares Outstanding (Basic)
414140393938
Shares Outstanding (Diluted)
414140393938
Shares Change (YoY)
1.43%1.67%1.77%1.21%1.74%1.00%
EPS (Basic)
-0.67-0.83-4.59-1.33-0.68-0.82
EPS (Diluted)
-0.67-0.83-4.59-1.33-0.68-0.82
Free Cash Flow
-14.59-20.31-35.69-9.13-22.910.38
Free Cash Flow Per Share
-0.35-0.50-0.89-0.23-0.590.27
Gross Margin
54.58%53.92%50.90%51.44%52.41%53.88%
Operating Margin
-8.60%-13.66%-63.32%-15.11%-9.00%-12.12%
Profit Margin
-9.02%-11.62%-60.66%-15.48%-8.40%-10.84%
FCF Margin
-4.75%-6.94%-11.74%-2.69%-7.24%3.57%
EBITDA
-2.5-14.15-164.72-20.310.88-9.37
EBITDA Margin
-0.81%-4.84%-54.20%-5.99%0.28%-3.22%
EBIT
-32.54-39.95-192.44-51.18-28.47-35.28
EBIT Margin
-8.60%-13.66%-63.32%-15.11%-9.00%-12.12%
Effective Tax Rate
0.01%0.11%3.80%3.66%11.36%12.49%
Updated Jan 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q